140 related articles for article (PubMed ID: 35272357)
21. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.
Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR
BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594
[TBL] [Abstract][Full Text] [Related]
23. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
25. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
27. Local Recurrence of Renal Cancer After Surgery: Prime Time for Percutaneous Thermal Ablation?
Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Orsi F
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1542-7. PubMed ID: 25902857
[TBL] [Abstract][Full Text] [Related]
28. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
29. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
30. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous ultrasound-guided radiofrequency ablation of an allograft renal cell carcinoma: a case report.
Olivani A; Iaria M; Missale G; Capocasale E; Biasini E; Mazzoni MP; Lombardelli L; Luzi E; Frattini A; Pelosi G
Transplant Proc; 2011 Dec; 43(10):3997-9. PubMed ID: 22172886
[TBL] [Abstract][Full Text] [Related]
32. Transarterial embolization of T1b and T2a renal cell carcinoma prior to percutaneous cryoablation: a retrospective comparative study.
Salei A; Raymond M; Savage C; Huang J; Caridi TM; Rais-Bahrami S; Gunn AJ
Abdom Radiol (NY); 2023 Feb; 48(2):773-779. PubMed ID: 36454278
[TBL] [Abstract][Full Text] [Related]
33. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study.
Umakoshi N; Iguchi T; Matsui Y; Tomita K; Uka M; Kawabata T; Munetomo K; Nagata S; Gobara H; Araki M; Hiraki T
Jpn J Radiol; 2023 Sep; 41(9):1007-1014. PubMed ID: 37002430
[TBL] [Abstract][Full Text] [Related]
34. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.
Ito K; Soga S; Seguchi K; Shinchi Y; Masunaga A; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Shinmoto H; Kaji T; Asano T
Oncol Lett; 2017 Jul; 14(1):918-924. PubMed ID: 28693252
[TBL] [Abstract][Full Text] [Related]
36. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.
Balageas P; Cornelis F; Le Bras Y; Hubrecht R; Bernhard JC; Ferrière JM; Ravaud A; Grenier N
Eur Radiol; 2013 Jul; 23(7):1925-32. PubMed ID: 23443351
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients.
Veltri A; De Fazio G; Malfitana V; Isolato G; Fontana D; Tizzani A; Gandini G
Eur Radiol; 2004 Dec; 14(12):2303-10. PubMed ID: 15599549
[TBL] [Abstract][Full Text] [Related]
38. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
[TBL] [Abstract][Full Text] [Related]
39. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience.
Wah TM; Lenton J; Smith J; Bassett P; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Kimuli M; Cartledge J
Eur Radiol; 2021 Oct; 31(10):7491-7499. PubMed ID: 33825033
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]